By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Discovery, development, and commercialization of therapeutics for rare endocrine diseases and7.7M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States7.7M100.00%